enVVeno Medical (NVNO)

• Market cap: $8.49M
• 1 day: -35.68%
• 5 days: -36.36%
• 1 month: -46.21%
• 3 months: -90.67%
• 6 months: -88.52%
• Year to date: -86.32%
• 1 year: -87.68%
• 5 years: -94.9%
• 10 years: -99.68%
• Sector: Healthcare
• Industry: Medical Devices

About: enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Employees: 37